Armata Pharmaceuticals (ARMP) Total Current Liabilities (2016 - 2026)
Quarterly results put Total Current Liabilities at $9.2 million for Q1 2026, down 91.65% from a year ago — trailing twelve months through Mar 2026 was $9.2 million (down 91.65% YoY), and the annual figure for FY2025 was $8.9 million, down 81.46%.
Armata Pharmaceuticals has reported Total Current Liabilities over the past 14 years, most recently at $9.2 million for Q1 2026.
- Total Current Liabilities reached $9.2 million in Q1 2026 per ARMP's latest filing, up from $8.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $140.0 million in Q3 2025 and bottomed at $6.2 million in Q1 2022.
- Median Total Current Liabilities over the past 5 years was $48.2 million (2024), compared with a mean of $57.4 million.
- The largest annual shift saw Total Current Liabilities soared 725.81% in 2023 before it plummeted 91.65% in 2026.
- Over 5 years, Total Current Liabilities stood at $24.9 million in 2022, then plummeted by 33.82% to $16.5 million in 2023, then surged by 193.11% to $48.2 million in 2024, then tumbled by 81.46% to $8.9 million in 2025, then grew by 3.14% to $9.2 million in 2026.
- Business Quant data shows Total Current Liabilities for ARMP at $9.2 million in Q1 2026, $8.9 million in Q4 2025, and $140.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 5.11 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 9.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.23 Mn |
| Dec 31, 2025 | 8.95 Mn |
| Sep 30, 2025 | 139.95 Mn |
| Jun 30, 2025 | 120.09 Mn |
| Mar 31, 2025 | 110.54 Mn |
| Dec 31, 2024 | 48.25 Mn |
| Sep 30, 2024 | 118.20 Mn |
| Jun 30, 2024 | 123.18 Mn |
| Mar 31, 2024 | 110.05 Mn |
| Dec 31, 2023 | 16.46 Mn |
| Sep 30, 2023 | 21.88 Mn |
| Jun 30, 2023 | 51.56 Mn |
| Mar 31, 2023 | 51.42 Mn |
| Dec 31, 2022 | 24.87 Mn |
| Sep 30, 2022 | 7.00 Mn |
| Jun 30, 2022 | 7.38 Mn |
| Mar 31, 2022 | 6.23 Mn |
| Dec 31, 2021 | 4.81 Mn |
| Sep 30, 2021 | 5.25 Mn |
| Jun 30, 2021 | 5.90 Mn |
| Mar 31, 2021 | 4.98 Mn |
| Dec 31, 2020 | 6.71 Mn |
| Sep 30, 2020 | 7.07 Mn |
| Jun 30, 2020 | 5.21 Mn |
| Mar 31, 2020 | 6.36 Mn |
| Dec 31, 2019 | 4.88 Mn |
| Sep 30, 2019 | 4.97 Mn |
| Jun 30, 2019 | 5.63 Mn |
| Mar 31, 2019 | 3.59 Mn |
| Dec 31, 2018 | 2.03 Mn |
| Sep 30, 2018 | 2.47 Mn |
| Jun 30, 2018 | 2.05 Mn |
| Mar 31, 2018 | 1.78 Mn |
| Dec 31, 2017 | 1.97 Mn |
| Sep 30, 2017 | 2.48 Mn |
| Jun 30, 2017 | 3.71 Mn |
| Mar 31, 2017 | 2.88 Mn |
| Dec 31, 2016 | 3.54 Mn |
| Sep 30, 2016 | 3.15 Mn |
| Jun 30, 2016 | 3.32 Mn |